|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000150 USD | 0.00% |
|
0.00% | -75.00% |
| 05-29 | Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 05-28 | Stemtech Corporation Auditor Raises 'Going Concern' Doubt | CI |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Revenues | 4.32M | 4.56M | 4.92M | 5.05M | 2.88M | ||
Total Revenues | 4.32M | 4.56M | 4.92M | 5.05M | 2.88M | ||
Cost of Goods Sold, Total | 1.02M | 1.16M | 1M | 1.33M | 567K | ||
Gross Profit | 3.3M | 3.4M | 3.92M | 3.73M | 2.31M | ||
Selling General & Admin Expenses, Total | 6.51M | 8.42M | 8.13M | 6.11M | 5.02M | ||
R&D Expenses | - | - | 13.8K | - | - | ||
Other Operating Expenses, Total | 6.51M | 8.42M | 8.14M | 6.11M | 5.02M | ||
Operating Income | -3.21M | -5.02M | -4.22M | -2.39M | -2.71M | ||
Interest Expense, Total | -8.33M | -4.1M | -4.89M | -1.58M | -1.45M | ||
Net Interest Expenses | -8.33M | -4.1M | -4.89M | -1.58M | -1.45M | ||
Other Non Operating Income (Expenses) | 4.43M | -3.22M | 1.51M | 85.36K | 111K | ||
EBT, Excl. Unusual Items | -7.11M | -12.34M | -7.61M | -3.88M | -4.05M | ||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | ||
Other Unusual Items | - | 3.8M | 2.18M | 108K | - | ||
EBT, Incl. Unusual Items | -7.11M | -8.54M | -5.43M | -3.77M | -4.05M | ||
Income Tax Expense | - | 95.62K | - | - | - | ||
Earnings From Continuing Operations | -7.11M | -8.63M | -5.43M | -3.77M | -4.05M | ||
Net Income to Company | -7.11M | -8.63M | -5.43M | -3.77M | -4.05M | ||
Minority Interest | 33.65K | 87.9K | 1.73K | 3.14K | 3.14K | ||
Net Income - (IS) | -7.08M | -8.54M | -5.43M | -3.77M | -4.05M | ||
Net Income to Common Incl Extra Items | -7.08M | -8.54M | -5.43M | -3.77M | -4.05M | ||
Net Income to Common Excl. Extra Items | -7.08M | -8.54M | -5.43M | -3.77M | -4.05M | ||
Per Share Items | |||||||
Net EPS - Basic | -0.19 | -0.19 | -0.07 | -0.03 | -0.02 | ||
Basic EPS - Continuing Operations | -0.19 | -0.19 | -0.07 | -0.03 | -0.02 | ||
Basic Weighted Average Shares Outstanding | 37.62M | 46.01M | 83.47M | 119M | 170M | ||
Net EPS - Diluted | -0.19 | -0.19 | -0.07 | -0.03 | -0.02 | ||
Diluted EPS - Continuing Operations | -0.19 | -0.19 | -0.07 | -0.03 | -0.02 | ||
Diluted Weighted Average Shares Outstanding | 37.62M | 46.01M | 83.47M | 119M | 170M | ||
Normalized Basic EPS | -0.12 | -0.17 | -0.06 | -0.02 | -0.01 | ||
Normalized Diluted EPS | -0.12 | -0.17 | -0.06 | -0.02 | -0.01 | ||
Supplemental Items | |||||||
EBITDA | -2.78M | -3.12M | -3.64M | -2.04M | -2.54M | ||
EBITA | -3.21M | -3.57M | -4.22M | -2.39M | -2.71M | ||
EBIT | -3.21M | -5.02M | -4.22M | -2.39M | -2.71M | ||
EBITDAR | -2.68M | -3.03M | -3.56M | - | - | ||
Effective Tax Rate - (Ratio) | - | -1.12 | - | - | - | ||
Normalized Net Income | -4.41M | -7.62M | -4.76M | -2.42M | -2.53M | ||
Supplemental Operating Expense Items | |||||||
Selling and Marketing Expenses | 1.75M | 1.58M | 1.69M | 880K | 464K | ||
General and Administrative Expenses | 4.75M | 6.84M | 6.44M | 5.23M | 4.55M | ||
Research And Development Expense From Footnotes | - | - | 13.8K | - | - | ||
Net Rental Expense, Total | 106K | 85.63K | 73.31K | - | - | ||
Imputed Operating Lease Interest Expense | 6.02M | 2.05M | 1.15M | - | - | ||
Imputed Operating Lease Depreciation | -5.92M | -1.97M | -1.08M | - | - | ||
Stock-Based Comp., Other (Total) | 1.03M | 4M | 893K | 1.19M | 1.57M | ||
Total Stock-Based Compensation | 1.03M | 4M | 893K | 1.19M | 1.57M |
- Stock Market
- Stocks
- STEK Stock
- Financials Stemtech Corporation
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















